Pfizer Inc. (PFE) makes a promising vaccine investment
Pfizer Inc. (NYSE: PFE) will collaborate on the development of a potential Lyme disease vaccine. The increasing number of people infected with this disease can assure a consistent demand for such a medicine. Pfizer Inc. (PFE) joined forces with Valneva in 2020 after the latter disclosed positive results from a phase II study of the […]
